ATE519783T1 - ßPHAGE DISPLAYß BIBLIOTHEKE VON MENSCHLICHEN VH FRAGMENTEN - Google Patents

ßPHAGE DISPLAYß BIBLIOTHEKE VON MENSCHLICHEN VH FRAGMENTEN

Info

Publication number
ATE519783T1
ATE519783T1 AT01271932T AT01271932T ATE519783T1 AT E519783 T1 ATE519783 T1 AT E519783T1 AT 01271932 T AT01271932 T AT 01271932T AT 01271932 T AT01271932 T AT 01271932T AT E519783 T1 ATE519783 T1 AT E519783T1
Authority
AT
Austria
Prior art keywords
fragments
ßphage
displayß
library
human
Prior art date
Application number
AT01271932T
Other languages
English (en)
Inventor
Jamshid Tahna
Jocelyn Entwistle
Saran Narang
Michael Dan
Colin Mackenzie
Original Assignee
Grad Carole Legal Representative Of Kaplan Howard
Tanha Jamshid
Jocelyn Entwistle
Saran Narang
Michael Dan
Mackenzie Colin R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grad Carole Legal Representative Of Kaplan Howard, Tanha Jamshid, Jocelyn Entwistle, Saran Narang, Michael Dan, Mackenzie Colin R filed Critical Grad Carole Legal Representative Of Kaplan Howard
Application granted granted Critical
Publication of ATE519783T1 publication Critical patent/ATE519783T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01271932T 2000-12-22 2001-12-21 ßPHAGE DISPLAYß BIBLIOTHEKE VON MENSCHLICHEN VH FRAGMENTEN ATE519783T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25803100P 2000-12-22 2000-12-22
PCT/CA2001/001845 WO2002051870A2 (en) 2000-12-22 2001-12-21 Phage display libraries of human vh fragments

Publications (1)

Publication Number Publication Date
ATE519783T1 true ATE519783T1 (de) 2011-08-15

Family

ID=22978807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271932T ATE519783T1 (de) 2000-12-22 2001-12-21 ßPHAGE DISPLAYß BIBLIOTHEKE VON MENSCHLICHEN VH FRAGMENTEN

Country Status (6)

Country Link
US (1) US8372954B2 (de)
EP (1) EP1345967B1 (de)
AT (1) ATE519783T1 (de)
CA (1) CA2447832C (de)
ES (1) ES2376454T3 (de)
WO (1) WO2002051870A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100430534B1 (ko) * 2001-05-23 2004-05-10 주식회사 마이크로아이디 단일가닥 디엔에이 분해효소를 이용하여 키메라 디엔에이라이브러리를 만드는 방법
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
GB0230203D0 (en) * 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
SI1639011T1 (sl) * 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
US8293233B2 (en) * 2005-03-25 2012-10-23 National Research Council Of Canada Method for isolation of soluble polypeptides
WO2009109572A2 (en) * 2008-03-03 2009-09-11 Ablynx Nv Monovalent phage display of single variable domains
PE20120591A1 (es) 2009-04-02 2012-05-23 Roche Glycart Ag Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla
WO2011034605A2 (en) 2009-09-16 2011-03-24 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
MX2012006406A (es) 2009-12-04 2012-07-25 Genentech Inc Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
EP2509626B1 (de) 2009-12-11 2016-02-10 F.Hoffmann-La Roche Ag Anti-vegf-c-antikörper und verfahren zu ihrer verwendung
JP5852010B2 (ja) 2009-12-23 2016-02-03 ジェネンテック， インコーポレイテッド 抗Ｂｖ８抗体およびその使用
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
US9637557B2 (en) 2010-04-23 2017-05-02 Genentech, Inc. Production of heteromultimeric proteins
CN102959097B (zh) 2010-07-08 2014-07-16 本田技研工业株式会社 高频加热用线圈
CN104474546A (zh) 2010-08-13 2015-04-01 弗·哈夫曼-拉罗切有限公司 用于疾病治疗的针对IL-1β和IL-18的抗体
RU2013110875A (ru) 2010-08-24 2014-09-27 Ф.Хоффманн-Ля Рош Аг БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
US9675693B2 (en) 2010-09-30 2017-06-13 Riken Methods and drugs targeting Eva1 or Ceacam1 gene expression for treatment and diagnosing of glioma
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
JP5883396B2 (ja) 2010-12-27 2016-03-15 国立大学法人名古屋大学 受容体型チロシンキナーゼが仲介する癌細胞の生存促進性シグナルを抑制する方法
US10689447B2 (en) 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
CN103649117B (zh) 2011-02-04 2016-09-14 霍夫曼-拉罗奇有限公司 Fc变体及其生成方法
JP5925783B2 (ja) 2011-08-12 2016-05-25 国立感染症研究所長 アスペルギルスフミガーツス感染症の検査、予防及び治療のための方法並びに組成物
CN104093744A (zh) 2011-10-11 2014-10-08 弗·哈夫曼-拉罗切有限公司 双特异性抗体的改进的组装
MX2014005330A (es) 2011-11-02 2014-09-08 Genentech Inc Cromatografia de sobrecarga y elucion.
MX2014009565A (es) 2012-02-10 2014-11-10 Genentech Inc Anticuerpos monocatenarios y otros heteromultimeros.
JP6263117B2 (ja) 2012-05-11 2018-01-17 公益財団法人微生物化学研究会 抗ｃｘａｄｒ抗体
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 少なくとも２つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
RU2015100656A (ru) 2012-06-27 2016-08-20 Ф. Хоффманн-Ля Рош Аг Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
EP2881467B1 (de) 2012-07-30 2018-10-31 National University Corporation Nagoya University Monoklonaler antikörper gegen menschlichen midkine
KR101796689B1 (ko) * 2012-08-22 2017-11-10 재단법인 목암생명과학연구소 안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용
RU2015122726A (ru) 2012-11-15 2017-01-10 Дженентек, Инк. ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
JP6357113B2 (ja) 2013-02-08 2018-07-11 株式会社医学生物学研究所 ヒトｎｒｇ１タンパク質に対する抗体
US9429584B2 (en) 2013-02-28 2016-08-30 National Cancer Center Antibody against insoluble fibrin
WO2014174596A1 (ja) 2013-04-23 2014-10-30 株式会社医学生物学研究所 ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体
HRP20190071T1 (hr) 2013-07-12 2019-02-22 F. Hoffmann - La Roche Ag Elucidacija optimizacije unosa kromatografijom ionske izmjene
CN105848746B (zh) 2013-09-05 2019-07-09 豪夫迈·罗氏有限公司 用于层析重复利用的方法
SG10201802525QA (en) 2013-09-13 2018-04-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
KR102332302B1 (ko) 2013-09-13 2021-12-01 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
EP3070167A4 (de) 2013-11-06 2017-06-07 Osaka University Antikörper mit breiter neutralisierender aktivität bei einem gruppe-1-influenza-a-virus
HUE063273T2 (hu) 2014-05-06 2024-01-28 Hoffmann La Roche Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával
EP3217787B1 (de) 2014-11-10 2019-04-17 F.Hoffmann-La Roche Ag Tiermodell für nephropathie und mittel zur behandlung davon
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies
ES2761726T3 (es) 2015-03-06 2020-05-20 Hoffmann La Roche DsbA y DsbC ultrapurificadas y procedimientos de preparación y uso de las mismas
MX2017012805A (es) 2015-04-07 2018-04-11 Genentech Inc Complejo de unión a antígenos con actividad agonista y métodos de uso.
EP3795679A1 (de) 2015-05-28 2021-03-24 Genentech, Inc. Zellbasierter test zum nachweis von anti-cd3-homodimeren
EP3408671B1 (de) 2016-01-25 2023-11-01 F. Hoffmann-La Roche AG Verfahren zum testen t-zell-abhängiger bispezifischer antikörper
EP3434690A4 (de) 2016-03-23 2020-04-01 Seoul National University R&DB Foundation An hüllglykoprotein von schwerem-fieber-mit-thrombozytopenie-syndrom-virus bindender antikörper sowie verwendung dafür
JP7359547B2 (ja) 2016-05-17 2023-10-11 ジェネンテック， インコーポレイテッド 免疫療法における診断及び使用のための間質遺伝子シグネチャー
ES2988363T3 (es) 2016-06-17 2024-11-20 Hoffmann La Roche Purificación de anticuerpos multiespecíficos
EP3475700A4 (de) 2016-06-26 2020-03-04 Gennova Biopharmaceuticals Limited Antikörper-phagendisplay-bibliothek
EP3494139B1 (de) 2016-08-05 2022-01-12 F. Hoffmann-La Roche AG Multivalente und multiepitopische anitikörper mit agonistischer wirkung und verfahren zur verwendung
JP6293829B2 (ja) * 2016-08-05 2018-03-14 モガム インスティチュート フォー バイオメディカル リサーチＭＯＧＡＭ Ｉｎｓｔｉｔｕｔｅ ｆｏｒ Ｂｉｏｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用
SG11201901228QA (en) 2016-08-15 2019-03-28 Genentech Inc Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
WO2020059847A1 (ja) 2018-09-21 2020-03-26 国立大学法人 東京医科歯科大学 ヒトｈｍｇｂ１に特異的に結合するヒトモノクローナル抗体、及びそれを含有するアルツハイマー病を治療又は予防するための医薬組成物
JP7607579B2 (ja) 2019-03-27 2024-12-27 ティガティーエックス， インコーポレイテッド 工学的に操作されたＩｇＡ抗体および使用方法
CN113711037A (zh) 2019-04-18 2021-11-26 基因泰克公司 抗体效力测定
TWI870412B (zh) 2019-06-05 2025-01-21 美商建南德克公司 過載層析管柱之再生方法
CA3173263A1 (en) 2020-03-30 2021-10-07 Yasuhiro Matsumura Antibody drug conjugate
EP4158014A2 (de) 2020-05-26 2023-04-05 Dionis Therapeutics, Inc. Bibliotheken künstlicher mini-proteome aus nukleinsäuren
KR20230073196A (ko) 2020-09-21 2023-05-25 제넨테크, 인크. 다중특이성 항체의 정제
US20240025985A1 (en) 2020-12-09 2024-01-25 National University Corporation Tokyo Medical And Dental University Agent for Preventing or Treating Frontotemporal Lobar Degeneration
CN116745620A (zh) 2021-01-14 2023-09-12 国立大学法人新潟大学 用于辅助肾病综合征的诊断的标志物及其应用
EP4426829A1 (de) 2021-11-01 2024-09-11 Dana-Farber Cancer Institute, Inc. Biologisch ausgewählte bibliotheken künstlicher miniproteome von nukleinsäuren
CN119213128A (zh) 2022-03-09 2024-12-27 株式会社丘阿德 与Eva1蛋白质结合的人源化抗体或其功能性片段、抗体药物缀合物和嵌合抗原受体
WO2023192622A1 (en) 2022-04-01 2023-10-05 Genentech, Inc. Hydroxypropyl methyl cellulose derivatives to stabilize polypeptides
WO2023238869A1 (ja) 2022-06-07 2023-12-14 国立大学法人 東京医科歯科大学 筋萎縮性側索硬化症、パーキンソン病、ハンチントン病、脊髄小脳失調症、老化に関連する変性疾患若しくは神経疾患、脳老化、あるいは脳老化を伴う疾患の予防剤又は治療剤
EP4619755A1 (de) 2022-11-18 2025-09-24 Genentech, Inc. Signalverstärkung und multiplexing unter verwendung von massenetiketten für ia-lc-ms/ms-basierte assays
KR20250116683A (ko) 2022-11-25 2025-08-01 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 혈액암에 대한 항체
KR20250134225A (ko) 2023-01-18 2025-09-10 니혼 유니버서티 점막 병변 환자에 대한 면역요법약에 의한 치료의 유효성을 예측하기 위한 방법 및 키트

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
US4754065A (en) 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
EP1498427B1 (de) 1992-08-21 2009-12-16 Vrije Universiteit Brussel Immunoglobuline ohne leichte Ketten
US5639863A (en) 1994-06-21 1997-06-17 Dan; Michael D. Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US6828422B1 (en) * 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
IL127127A0 (en) * 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
WO2001018058A2 (en) 1999-09-07 2001-03-15 Viventia Biotech Inc. Enhanced phage display library of human vh fragments and methods for producing same
DE60143798D1 (de) * 2000-06-16 2011-02-17 Cambridge Antibody Tech Immunspezifisch bindende antikörper gegen blys
WO2002028903A2 (en) * 2000-09-13 2002-04-11 Crucell Holland B.V. Heavy chain libraries

Also Published As

Publication number Publication date
CA2447832C (en) 2012-09-25
CA2447832A1 (en) 2002-07-04
EP1345967B1 (de) 2011-08-10
WO2002051870A3 (en) 2003-04-24
WO2002051870A2 (en) 2002-07-04
EP1345967A2 (de) 2003-09-24
ES2376454T3 (es) 2012-03-14
US8372954B2 (en) 2013-02-12
US20050164180A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
ATE519783T1 (de) ßPHAGE DISPLAYß BIBLIOTHEKE VON MENSCHLICHEN VH FRAGMENTEN
WO2001018058A3 (en) Enhanced phage display library of human vh fragments and methods for producing same
DK0934526T3 (da) Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål
DE60217916D1 (de) Anzeigetafel und anzeigetafelansteuerverfahren
NO20020537D0 (no) Animert skjermobjekt for avmerking og valg av videosekvenser
NO20015907L (no) Skjermenhet, driverfremgangsmåte av den, og portabelt terminalutstyr
IL157794A0 (en) Method to screen peptide display libraries using minicell display
NO20054789D0 (no) Sammensetninger inneholdende piperaciliin og tazobactam nytting for injeksjon
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
DK1481059T3 (da) Eukaryote signalsekvenser for polypeptidekspression og polypeptiddisplaybiblioteker
DK1266025T3 (da) Protein-scaffolds for antistof-mimetika og andre bindingsproteiner
WO2005003899A3 (en) Method, system and apparatus for information delivery
HRP20031058B1 (hr) Stalak jedinice informacijskog prikazivača, koji ima barem jedno prezentacijsko lice
EP1188781A4 (de) Schlagzäh-modifizierer und diese modifizierer enthaltende polyesterzusammensetzung
DK1549333T3 (da) Compstatinanaloge med forbedret aktivitet
DE60102956D1 (de) Verfahren zur Tastenanordnung von Tastaturen und entsprechende Tastatur
IS6820A (is) Frostþurrkuð pantóprasólblanda og pantóprasólinnsprautun
DE10196554T1 (de) Synchronisation von Audio- und Videosignalen
NO20021396D0 (no) Flytende krystallskjermpanel og produksjonsmetoder av denne og flytende krystallskjermapparater
EP1572719A4 (de) Partielle peptidmimetika und verfahren
DE60324070D1 (de) Plasma Anzeige Paneel - Reduktion des Zitter-Rauschens bei Anzeige von weniger Video-Stufen als gefordert
FR2806515B1 (fr) Ecran acoustique et ses elements constitutifs
EA200501387A1 (ru) Устройство и способ отображения информации
DE602004021149D1 (de) Auswahl des Wiedergabemodus basierend auf Eingabefarbraum und Objekttype
DE60121424D1 (de) Verfahren zum sichtbar machen von audiovisuellen fernsehsendungen und zugeordnetes sichtgerät

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties